The impact of being in the COVID-19 pandemic on in-hospital mortality of non-infected patients aged 80 years and older with ST-elevation myocardial ınfarction.
作者信息
Ebik Mustafa, Gürdoğan Muhammet, Özkan Uğur
机构信息
Department of Cardiology, Edirne Sultan 1. Murat State Hospital, Edirne, Turkey.
Department of Cardiology, School of Medicine, Trakya University, Edirne, Turkey.
出版信息
J Geriatr Cardiol. 2024 Jul 28;21(7):768-774. doi: 10.26599/1671-5411.2024.07.008.
Abstract
摘要
相似文献
1
The impact of being in the COVID-19 pandemic on in-hospital mortality of non-infected patients aged 80 years and older with ST-elevation myocardial ınfarction.2019年冠状病毒病大流行对80岁及以上非感染性ST段抬高型心肌梗死患者院内死亡率的影响。
J Geriatr Cardiol. 2024 Jul 28;21(7):768-774. doi: 10.26599/1671-5411.2024.07.008.
2
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction.COVID-19 大流行、机械再灌注与 ST 段抬高型心肌梗死 30 天死亡率。
Heart. 2022 Mar;108(6):458-466. doi: 10.1136/heartjnl-2021-319750. Epub 2021 Oct 28.
3
Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry).新型冠状病毒肺炎疫情对土耳其 ST 段抬高型心肌梗死（STEMI）患者的影响：TURSER 研究（土耳其 ST 段抬高型心肌梗死注册研究）结果。
J Thromb Thrombolysis. 2022 Feb;53(2):321-334. doi: 10.1007/s11239-021-02487-3. Epub 2021 May 29.
4
Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease.经血管造影证实患有冠状动脉疾病的老年ST段抬高型与非ST段抬高型心肌梗死患者的短期和长期预后差异。
Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):513-22. doi: 10.1161/CIRCOUTCOMES.115.002312. Epub 2016 Sep 6.
5
Comparison of door-to-balloon time and in-hospital outcomes in patients with ST-elevation myocardial infarction between before versus after COVID-19 pandemic.比较 COVID-19 大流行前后 ST 段抬高型心肌梗死患者的门球时间和住院结局。
Cardiovasc Interv Ther. 2022 Oct;37(4):641-650. doi: 10.1007/s12928-022-00836-4. Epub 2022 Jan 10.
6
Decreased door-to-balloon time in patients with ST-segment elevation myocardial infarction during the early COVID-19 pandemic in South Korea: An observational study.韩国 COVID-19 大流行早期 ST 段抬高型心肌梗死患者门球时间缩短：一项观察性研究。
Medicine (Baltimore). 2022 Jul 29;101(30):e29596. doi: 10.1097/MD.0000000000029596.
7
Impact of Coronavirus Disease 2019 Pandemic on the Incidence and Management of Out-of-Hospital Cardiac Arrest in Patients Presenting With Acute Myocardial Infarction in England.新型冠状病毒病 2019 大流行对英格兰因急性心肌梗死而出现院外心脏骤停患者的发生率和处理的影响。
J Am Heart Assoc. 2020 Nov 17;9(22):e018379. doi: 10.1161/JAHA.120.018379. Epub 2020 Oct 7.
8
Impact of the COVID-19 Pandemic on ST-elevation Myocardial Infarction from a Single-center Experience in Tokyo.COVID-19 大流行对东京单中心 ST 段抬高型心肌梗死的影响。
Intern Med. 2021 Dec 1;60(23):3693-3700. doi: 10.2169/internalmedicine.8220-21. Epub 2021 Sep 25.
9
Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction.COVID-19 大流行对急性心肌梗死患者的就诊延迟和临床结局的影响。
J Korean Med Sci. 2022 May 30;37(21):e167. doi: 10.3346/jkms.2022.37.e167.
10
orth merican OVID-19 ST-Segment-Elevation yocardial nfarction (NACMI) registry: Rationale, design, and implications.美国 OVID-19 段抬高型心肌梗死（NACMI）登记研究：原理、设计和意义。
Am Heart J. 2020 Sep;227:11-18. doi: 10.1016/j.ahj.2020.05.006. Epub 2020 May 16.
本文引用的文献
1
Myocardial Infarction Across COVID-19 Pandemic Phases: Insights From the Veterans Health Affairs System.新冠肺炎大流行各阶段的心肌梗死：来自退伍军人健康事务系统的见解。
J Am Heart Assoc. 2023 Jul 18;12(14):e029910. doi: 10.1161/JAHA.123.029910. Epub 2023 Jul 8.
2
Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry.COVID-19大流行对ST段抬高型心肌梗死机械再灌注及30天死亡率的年龄相关影响：ISACS-STEMI COVID-19注册研究结果
J Clin Med. 2023 Mar 8;12(6):2116. doi: 10.3390/jcm12062116.
3
Age-Related Mortality in STEMI Patients: Insight from One Year of HUB Centre Experience during the Pandemic.ST段抬高型心肌梗死患者的年龄相关死亡率：疫情期间HUB中心一年经验的洞察
J Cardiovasc Dev Dis. 2022 Dec 2;9(12):432. doi: 10.3390/jcdd9120432.
4
Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association.老年人群急性冠状动脉综合征的管理：美国心脏协会的科学声明。
Circulation. 2023 Jan 17;147(3):e32-e62. doi: 10.1161/CIR.0000000000001112. Epub 2022 Dec 12.
5
COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication.新型冠状病毒肺炎与心血管疾病：临床表现、病理生理学、疫苗接种及长期影响。
Curr Med Res Opin. 2022 Jul;38(7):1071-1079. doi: 10.1080/03007995.2022.2078081. Epub 2022 Jun 3.
6
COVID-19: cardiovascular manifestations-a review of the cardiac effects.新型冠状病毒肺炎：心血管表现——心脏影响的综述
J Geriatr Cardiol. 2022 Mar 28;19(3):245-250. doi: 10.11909/j.issn.1671-5411.2022.03.007.
7
Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China.中国北京 COVID-19 大流行对 STEMI 患者行直接经皮冠状动脉介入治疗的影响。
Am J Emerg Med. 2022 Mar;53:68-72. doi: 10.1016/j.ajem.2021.11.034. Epub 2021 Nov 24.
8
Acute Coronary Syndrome in the Older Patient.老年患者的急性冠状动脉综合征
J Clin Med. 2021 Sep 14;10(18):4132. doi: 10.3390/jcm10184132.
9
Prolonged symptom onset to admission time is associated with severe Coronavirus disease: A meta combined propensity-adjusted analysis.症状出现到入院时间延长与严重冠状病毒病有关：一项荟萃联合倾向调整分析。
J Med Virol. 2021 Dec;93(12):6714-6721. doi: 10.1002/jmv.27253. Epub 2021 Aug 12.
10
ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France.ST 段抬高型心肌梗死：法国 COVID-19 大流行期间的管理和预后相关性。
Arch Cardiovasc Dis. 2021 May;114(5):340-351. doi: 10.1016/j.acvd.2021.01.005. Epub 2021 Apr 14.
Zotero 插件